Open AccessWays to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a)
Author(s) -
A. N. Boyko
Publication year - 2022
Publication title -
nevrologiâ, nejropsihiatriâ, psihosomatika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.157
H-Index - 9
eISSN - 2310-1342
pISSN - 2074-2711
DOI - 10.14412/2074-2711-2022-1s-34-37
Subject(s) - multiple sclerosis , medicine , pegylation , adverse effect , pegylated interferon , interferon beta 1b , drug , intensive care medicine , interferon beta , pharmacology , immunology , virus , peg ratio , hepatitis c virus , ribavirin , finance , economics